ASTRAZENECA PHARMA INDIA
Back to Balance Sheet
|
ASTRAZENECA PHARMA INDIA Last 5 Year Total Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹467 Cr | ₹484 Cr | ₹392 Cr | ₹373 Cr | ₹367 Cr |
What is the latest Total Current Liabilities ratio of ASTRAZENECA PHARMA INDIA ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹467 Cr |
Mar2023 | ₹484 Cr |
Mar2022 | ₹392 Cr |
Mar2021 | ₹373 Cr |
Mar2020 | ₹367 Cr |
How is Total Current Liabilities of ASTRAZENECA PHARMA INDIA Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹467 Cr | -3.56 | |
Mar2023 | ₹484 Cr | 23.48 | |
Mar2022 | ₹392 Cr | 5.05 | |
Mar2021 | ₹373 Cr | 1.72 | |
Mar2020 | ₹367 Cr | - |
Compare Total Current Liabilities of peers of ASTRAZENECA PHARMA INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ASTRAZENECA PHARMA INDIA | ₹15,938.6 Cr | -1.9% | -1.9% | 19.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹446,684.0 Cr | 2.9% | 6.4% | 48.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,935.0 Cr | 0.5% | -2.1% | 59.2% | Stock Analytics | |
CIPLA | ₹121,639.0 Cr | 2.3% | 1% | 20.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹115,931.0 Cr | 3.5% | 15.7% | 20.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,876.4 Cr | -0.1% | 2.3% | 41.1% | Stock Analytics |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ASTRAZENECA PHARMA INDIA | -1.9% |
-1.9% |
19.3% |
SENSEX | -0.7% |
-1.6% |
11.1% |
You may also like the below Video Courses